參考文獻

1.Kim HW，Greenburg AG. Artificial Oxygen Carriers as Red Blood Cell Substitutes：A Selected Review and Current Status[J]. Artif Organs，2004，28（9）：813-828.

2.Thuillier R，Codas R，Marchand E，et al. Chronic renoprotective effect of pulsatile perfusion machine RM3 and IGL-1 solution in a preclinical kidney transplantation model[J]. J Transl Med，2012，10：233.

3.Timsit MO，Tullius SG. Hypothermic kidney preservation：a remembrance of the past in the future[J]?Curr Opin Organ Transplant，2011，16（2）：162-168.

4.Schreinemachers MC，Doorschodt BM，Florquin S，et al. Improved preservation and microcirculation with POLYSOL after transplantation in a porcine kidney autotransplantation model[J]. Nephrol Dial Transplant，2009，24（3）：816-824.

5.Minor T，Paul A，Efferz P，et al. Kidney transplantation after oxygenated machine perfusion preservation with Custodiol-N solution[J]. Transpl Int，2015，28（9）：1102-1108.

6.Fontes P，Lopez R，van der Plaats A，et al. Liver preservation with machine perfusion and a newly developed cellfree oxygen carrier solution under subnormothermic conditions[J]. Am J Transplant，2015，15（2）：381-394.

7.Monbaliu D，Brassil J. Machine perfusion of the liver：past，present and future[J]. Curr Opin Organ Transplant，2010，15（2）：160-166.

8.Gallinat A，Lüer B，Swoboda S，et al. Use of the new preservation solution Custodiol-N supplemented with dextran for hypothermic machine perfusion of the kidney[J]. Cryobiology，2013，66（2）：131-135.

9.Koch A，Loganathan S，Radovits T，et al. Deferoxamine，the newly developed iron chelator LK-614 and N-α-acetyl-histidine in myocardial protection[J]. Interact Cardiovasc Thorac Surg，2010，10（2）：181-184.

10.Veres G，Radovits T，Merkely B，et al. Custodiol-N，the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass[J]. J Cardiothorac Surg，2015，10：27.